Get started
Author

Yiwei Wang

Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
2018 · Hangcheng Fu, Yu Zhu, et al. · Clinical Cancer Research · 202
Intratumoral TIGIT+ CD8+ T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer
2020 · Zhaopei Liu, Quan Zhou, et al. · Journal for ImmunoTherapy of Cancer · 145
PDF
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients
2020 · Yu Qi, Yu Xia, et al. · Cancer Immunology Immunotherapy · 132
Biodegradable Anti‐Biofilm Fiber‐Membrane Ureteral Stent Constructed with a Robust Biomimetic Superhydrophilic Polycationic Hydration Surface Exhibiting Synergetic Antibacterial and Antiprotein Properties
2021 · Liheng Gao, Xingxing Liu, et al. · Small · 64
Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer
2017 · Yiqun Shao, Wenjing Zhu, et al. · OncoTargets and Therapy · 62
PDF
CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer
2018 · Qi Jiang, Qiang Fu, et al. · Cancer Immunology Immunotherapy · 59
Histamine upregulates the expression of histamine receptors and increases the neuroprotective effect of astrocytes
2018 · Jiawen Xu, Xiang Zhang, et al. · Journal of Neuroinflammation · 59
PDF
Tumor-infiltrating TNFRSF9 + CD8 + T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response
2020 · Yaohui Li, Zewei Wang, et al. · OncoImmunology · 57
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response
2019 · Yangyang Qi, Yuan Chang, et al. · Cancer Immunology Immunotherapy · 52
The Mast Cell Is an Early Activator of Lipopolysaccharide-Induced Neuroinflammation and Blood-Brain Barrier Dysfunction in the Hippocampus
2020 · Yiwei Wang, Huanhuan Sha, et al. · Mediators of Inflammation · 43
PDF
Neuroimmune connections between corticotropin-releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseases
2021 · Hong-Quan Dong, Yan-Ning Qian, et al. · Neural Regeneration Research · 41
Effect of Forsythiaside A on the RLRs Signaling Pathway in the Lungs of Mice Infected with the Influenza A Virus FM1 Strain
2019 · Xiao Zheng, Yingjie Fu, et al. · Molecules · 36
PDF
LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment
2023 · Huiwen Liu, Honglan Wang, et al. · Acta Pharmaceutica Sinica B · 34
High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
2016 · Wei Xi, Li Liu, et al. · Scientific Reports · 32
PDF
Intratumoral IL22‐producing cells define immunoevasive subtype muscle‐invasive bladder cancer with poor prognosis and superior nivolumab responses
2019 · Han Zeng, Zheng Liu, et al. · International Journal of Cancer · 27
PDF
Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma
2017 · Yidong Liu, Zheng Liu, et al. · Urologic Oncology Seminars and Original Investigations · 27
Eucalyptol, limonene and pinene enteric capsules attenuate airway inflammation and obstruction in lipopolysaccharide-induced chronic bronchitis rat model via TLR4 signaling inhibition
2024 · Xin-Yu Qiu, Li-Shan Yan, et al. · International Immunopharmacology · 25
Differences and Similarities Between Primary Open Angle Glaucoma and Primary Angle-Closure Glaucoma
2024 · Yiwei Wang, Yanzhi Guo, et al. · Eye and Brain · 24
Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin + cell abundance
2020 · Quan Zhou, Zewei Wang, et al. · OncoImmunology · 20
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients
2019 · Yang Qu, Zhiyuan Lin, et al. · Urologic Oncology Seminars and Original Investigations · 17
High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients
2016 · Hangcheng Fu, Yu Zhu, et al. · Oncotarget · 14
PDF
Tumor-infiltrating IL-17A + cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer
2020 · Zewei Wang, Quan Zhou, et al. · OncoImmunology · 12
PDF
Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5 + CD8 + T cell abundance
2020 · Qiuren Huang, Quan Zhou, et al. · OncoImmunology · 12
Intratumoral CCR5 + neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses
2020 · Zhuoyi Xiang, Quan Zhou, et al. · OncoImmunology · 11
PDF
Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways
2023 · Li-Shan Yan, Shuang Cui, et al. · Drug Design Development and Therapy · 10
PDF
Works count: 32
Citation count: 1,235
H-index: 19
I10-index: 25
Year
Topic
Type